Sources of regional variation in Medicare Part D drug spending (Q35773656)

10 August 2017

title

Sources of regional variation in Medicare Part D drug spending (English)

1 reference

10 August 2017

1

1 reference

10 August 2017

7

Jonathan Skinner

1 reference

10 August 2017

Nancy E Morden

2

1 reference

10 August 2017

Walid F Gellad

3

1 reference

10 August 2017

Julie P Bynum

4

1 reference

10 August 2017

Weiping Zhou

5

1 reference

10 August 2017

Joseph T Hanlon

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 February 2012

1 reference

The New England Journal of Medicine

10 August 2017

published in

1 reference

10 August 2017

volume

366

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

530-538

1 reference

Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Geographic variation in Medicare drug spending

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Regional variations in diagnostic practices

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Hospital quality and intensity of spending: is there an association?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

How much do patients' preferences contribute to resource use?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Slowing the growth of health care costs--lessons from regional variation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Potential Savings from an Evidence-Based Consumer-Oriented Public Education Campaign on Prescription Drugs

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Telmisartan, ramipril, or both in patients at high risk for vascular events

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Appropriate prescribing in elderly people: how well can it be measured and optimised?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Economic implications of evidence-based prescribing for hypertension: can better care cost less?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

The effect of incentive-based formularies on prescription-drug utilization and spending

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Diagnosis-based risk adjustment for medicare prescription drug plan payments.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285245

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions

25 September 2018

1 reference

12 December 2020

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease

1 reference

12 December 2020

Getting past denial--the high cost of health care in the United States

1 reference

12 December 2020

Generic drugs revisited

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMSA1104816

1 reference

10 August 2017

1 reference

10 August 2017

1 reference